Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial

Published:2019-11 Issue:11 Volume:20 Page:1587-1601
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tan Antoinette R,Wright Gail S,Thummala Anu R,Danso Michael A,Popovic Lazar,Pluard Timothy J,Han Hyo S,Vojnović Željko,Vasev Nikola,Ma Ling,Richards Donald A,Wilks Sharon T,Milenković Dušan,Yang Zhao,Antal Joyce M,Morris Shannon R,O'Shaughnessy Joyce

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007

2. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype;Cheang;Clin Cancer Res,2008

3. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

4. Cytotoxic chemotherapy: still the mainstay of clinical practice for all subtypes metastatic breast cancer;Twelves;Crit Rev Oncol Hematol,2016

5. Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer;O'Shaughnessy;J Clin Oncol,2014

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment;Bioorganic Chemistry;2024-08

2. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets;The FASEB Journal;2024-06-07

3. Proteomic Analysis Reveals Trilaciclib-Induced Senescence;Molecular & Cellular Proteomics;2024-06

4. A Phase I Study of sequences of the CDK4/6 Inhibitor, Ribociclib Combined with Gemcitabine in Patients with Advanced Solid Tumors;2024-04-25

5. Proteomic Analysis Reveals Trilaciclib-Induced Senescence;2024-03-14